181 related articles for article (PubMed ID: 19965683)
1. Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.
Haynes RA; Ware E; Premanandan C; Zimmerman B; Yu L; Phipps AJ; Lairmore MD
Blood; 2010 Jan; 115(4):815-23. PubMed ID: 19965683
[TBL] [Abstract][Full Text] [Related]
2. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
[TBL] [Abstract][Full Text] [Related]
3. Early spatial and temporal events of human T-lymphotropic virus type 1 spread following blood-borne transmission in a rabbit model of infection.
Haynes RA; Zimmerman B; Millward L; Ware E; Premanandan C; Yu L; Phipps AJ; Lairmore MD
J Virol; 2010 May; 84(10):5124-30. PubMed ID: 20219918
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.
Hiraragi H; Kim SJ; Phipps AJ; Silic-Benussi M; Ciminale V; Ratner L; Green PL; Lairmore MD
J Virol; 2006 Apr; 80(7):3469-76. PubMed ID: 16537614
[TBL] [Abstract][Full Text] [Related]
5. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo.
Bartoe JT; Albrecht B; Collins ND; Robek MD; Ratner L; Green PL; Lairmore MD
J Virol; 2000 Feb; 74(3):1094-100. PubMed ID: 10627519
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a seronegative human T-cell leukemia virus type 1 (HTLV-1) carrier state in rats inoculated with a syngeneic HTLV-1-immortalized T-cell line preferentially expressing Tax.
Koya Y; Ohashi T; Kato H; Hanabuchi S; Tsukahara T; Takemura F; Etoh K; Matsuoka M; Fujii M; Kannagi M
J Virol; 1999 Aug; 73(8):6436-43. PubMed ID: 10400737
[TBL] [Abstract][Full Text] [Related]
7. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
[TBL] [Abstract][Full Text] [Related]
8. The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.
Vine AM; Heaps AG; Kaftantzi L; Mosley A; Asquith B; Witkover A; Thompson G; Saito M; Goon PK; Carr L; Martinez-Murillo F; Taylor GP; Bangham CR
J Immunol; 2004 Oct; 173(8):5121-9. PubMed ID: 15470056
[TBL] [Abstract][Full Text] [Related]
9. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate.
Traina-Dorge VL; Martin LN; Lorino R; Winsor EL; Beilke MA
J Infect Dis; 2007 Feb; 195(4):562-71. PubMed ID: 17230416
[TBL] [Abstract][Full Text] [Related]
10. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
11. Relationship between anti-Tax antibody responses and cocultivatable virus in HTLV-I-infected rabbits.
Lydy SL; Conner ME; Marriott SJ
Virology; 1998 Oct; 250(1):60-6. PubMed ID: 9770420
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.
Ye J; Silverman L; Lairmore MD; Green PL
Blood; 2003 Dec; 102(12):3963-9. PubMed ID: 12907436
[TBL] [Abstract][Full Text] [Related]
13. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
14. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
15. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
16. Human T lymphotropic virus type 1 SU residue 195 plays a role in determining the preferential CD4+ T cell immortalization/transformation tropism.
Kannian P; Fernandez S; Jones KS; Green PL
J Virol; 2013 Aug; 87(16):9344-52. PubMed ID: 23785214
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms affecting HTLV type 1-dependent fusion at the cell membrane: implications for inhibiting viral transmission.
Daenke S; Booth S
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1731-6. PubMed ID: 11080818
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo.
Martinez MP; Cheng X; Joseph A; Al-Saleem J; Panfil AR; Palettas M; Dirksen WP; Ratner L; Green PL
Retrovirology; 2019 Dec; 16(1):44. PubMed ID: 31864373
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the antibody response to the HTLV-I gag and env proteins in HTLV-I asymptomatic carriers and HAM/TSP patients: an isotype and subclass analysis.
Dekaban GA; King EE; Arp J; Palker TJ; Rice GP
Scand J Immunol; 1994 Aug; 40(2):171-80. PubMed ID: 8047838
[TBL] [Abstract][Full Text] [Related]
20. HTLV-1 intragenic viral enhancer influences immortalization phenotype
Maksimova V; Smith S; Seth J; Phelps C; Niewiesk S; Satou Y; Green PL; Panfil AR
Front Immunol; 2022; 13():954077. PubMed ID: 35958554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
